The complete nucleotide sequence of the type I dihydrofolate reductase gene from Tn7 was determined. The structural gene coded for a polypeptide of 157 amino acid residues. The polypeptide deduced from the DNA sequence had a molecular weight of 17,577 which was in good agreement with that estimated by mobility in SDSpolyacrylamide gels. Sequences were identified proximal to the coding region which were similar to those found in the consensus E. coli promoter region and for the initiation of protein synthesis. Features consistent with the termination of RNA transcription were present distal to the structural gene. No homology was apparent when the DNA sequence of the type I gene was compared to the sequence of the type II plasmid DHFR genes, but sequence homology was evident when the type I and E. coli chromosomal enzymes were compared. Homology was greatest in the regions coding for amino acids which in the E. coli chromosomal enzyme are associated with substrate, cofactor and inhibitor binding.
INTRODUCTION
Trimethoprim (Tp) is an inhibitor of dihydrofolate reductase (DHFR), the enzyme which catalyzes the reduction of dihydrofolate to tetrahydrofolate in the presence of NADPH. In bacteria, resistance to trimethoprim occurs when chromosomal mutations lead to overproduction of the enzyme or to structural alteration of the gene product.! Resistance to trimethoprim in bacteria may also be mediated by R-plasmids coding for additional dihydrofolate reductases which have lower binding affinities for trimethoprim than has the bacterial enzyme. Trimethoprim-resistant plasmid DHFRs may be distinguished from one another and from bacterial enzymes by their inhibitor profiles for antifolate compounds, ^ immunological cross-reactivity, subunit structure and molecular weight, 3 and DNA-DNA hybridization. 4 According to these criteria, three classes of plasmid DHFRs have been established which differ considerably in the concentration of trimethoprim required to inhibit 5096 of the activity (150). The 150 values of the plasmid enzymes vary from 2.1 uM for the type III 4 , to 50-70 uM for the type I and 70,000 uM for the type II enzymes. 2 Like the E. coli chromosomal enzyme, the type III enzyme appears to be a single polypeptide, although it has a molecular weight of 16,900, a value slightly smaller than that found for the chromosomal DHFR. The type III enzyme does not appear to share antigenic determinants with any of the known plasmid or bacterial enzymes nor DNA homology at a level detectable by standard DNA-DNA hybridization methods.* The type II enzymes encoded by plasmids R67 and R388 are composed of four identical polypeptides, each having 78 amino acid residues. 5 ' 6 That these enzymes are homogeneous as a class has been shown by comparing primary structural data;^> 6 >ĥ owever, they bear no resemblance to any bacterial or eucaryotic DHFRs which have been characterized. 6 Type I enzymes also have subunit structure, but differ from the type II in that they are composed of two subunits which have molecular weights of 18,000. Although the type I plasmid enzyme has appeared to be distinct from the sensitive bacterial enzyme of E. coli, the observation that the type I subunit and the E. coli enzyme have similar molecular weights estimated by mobility in denaturing polyacrylamide gels may indicate some similarity which other criteria have failed to reveal. Another interesting feature of the type I DHFR from plasmid R483 8 is its presence on the transposon Tn7.9 This 13.6 Kb transposon which encodes both trimethoprim and streptomycin resistance, has been shown to integrate preferentially into a specific site of the E. coll chromosome with high efficiency.
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The nature and diversity of plasmid DHFR genes assume more significance when the clinical importance of strains containing these genes is considered. Although the proportion of trimethoprim-resistant pathogens is currently rather low, all three classes of plasmid genes are becoming more prevalent.4,11,12 The dissemination of plasmid-borne DHFR genes can occur by plasmid transfer, as well as by transpositional events involving Tn7. 12 The purpose of this study was to determine the nucleotide sequence of the type I DHFR gene which is situated on Tn7 in the hope that basic questions regarding the nature and organization of this gene and its gene product might be answered.
MATERIALS AND METHODS
Bacterial Strains, Plasmids and Bacteriophages E. coli K12, C600 containing plasmid pFE506 3 was used as a source of DNA specifying the type I DHFR gene from Tn7. The cloning vector was plasmid pBR322.
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The specialized host E. coli K12, JM103 and the viral stocks M13mp8 and mp9 were acquired from Bethesda Research Laboratories, Inc. and propagated as previously described. 1 *
Molecular Cloning and Clone Analysis
Partial restriction endonuclease digestion products were obtained by incubating 5 ug of pFE506 DNA with one unit of TaqI (Bethesda Research Laboratories, Inc.) for 45 min, under conditions suggested by the supplier. Ligation conditions, preparation of frozen competent cells and selection for trimethoprim resistance have been described. 3 The transformed strains were analyzed for plasmid content using a rapid plasmid DMA extraction procedure. 15 RF DNA from recombinant M13 derivatives was analyzed in the same manner. Single-stranded DNA was analyzed by hybridization as previously described. 16 Isolation of DNA Fragments and Gel Eleetrophoresis Preparative amounts of the 1680 bp EcoRI-Hindlll fragment from pFE872 carrying the type I gene were obtained by digesting the DNA with EcoRI and Hindlll and isolating the fragment from the acrylamide portion of a combination 1.096 agarose-4.0% acrylamide gel. Further purification was achieved by passage over a DEAEcellulose column. 17 The larger DNA species such as M13mp8 or mp9 which had been linearized were isolated by electrophoresis in 1.0% low melting point agarose as previously described. 3 Template Preparation and DNA Sequencing Tn7 DNA was subcloned into mp8 and mp9 derivatives of M13 according to established procedures. 1 * Recombinant viral genomes used as sequencing templates were isolated by growing the infected culture for 6 to 8 hr in 10-20 ml volumes. The viral particles were either removed from the culture supernatants by the usual polyethylene glycol precipitation, 16 or occasionally by the method of Schreier and
Cortese which does not use polyethylene glycol. ^ The single-stranded DNA was purified by phenol, chloroform and ether extraction as previously described. 16 The nucleotide sequence was determined using the chain termination method of Sanger et al. 19 Most of the sequence data were generated with a 17 base primer (P~L Biochemicals, Inc.) which anneals at positions 6278-6294 in M13mp8. Less satisfactory were sequence reactions using a 15 base primer (New England Biolabs) which anneals at positions 6297-6310. 20 Deoxyribonucleoside triphosphates and dideoxyribonucleoside triphosphates were purchased from Boehringer Mannheim. (a 3 2p)-dATP was supplied by New England Nuclear. DNA polymerase I, Klenow fragment, was obtained from New England Nuclear or Boehringer Mannheim. The sequence reactions were analyzed on thin (0.4 mm) sequencing gels (7.0 M urea-8.0% acrylamide). Gel reading ambiguities resulting from runs of C residues were resolved by incorporating cytosine S-D-arabinofuranoside 5'-triphosphate (P-L Biochemicals, Inc.) in the C reactions. 21 Anomalous spacing of C and G residues was reduced by using gels containing 85% formamide instead of 7.0 M urea. Computer Analysis of DNA Sequence Data DNA sequence data were analyzed using computer programs which were kindly provided by R. J. Roberts, Cold Spring Harbor Laboratories.22
RESULTS

Construction and Analysis of Trimethoprim-Resistant Hybrid Plasmids
Plasmid pFE506 
Subcloning into Derivatives of M13
Plasmid pFE872 was used to supply preparative amounts (100 yg) of Tn7 DNA for subcloning into M13 derivatives, mp8 and mp9. The Tn7 DNA was separated from vector DNA by a double digestion using EcoRI and Hindlll. Purified fragment DNA was digested with the restriction enzymes Sau3A, TaqI, Hpall, or Hpal, which were chosen for the construction of subclones on the basis of restriction mapping (data not shown). These enzymes generated small fragments which were clustered within an 883 bp region as shown in Figure 2 . When these fragments were cloned and used as templates, sequence data were acquired in an overlapping fashion from both strands. structural gene are displayed in Figure 3 . Reading frames large enough to code for the type I enzyme subunit were defined by a GTG (position 236) or an ATG (position 251) and the sequence TAA at position 709. The translation of the reading frame from the ATG codon produced an amino acid sequence which corresponded to part of the amino terminal sequence which had been determined using purified type I protein (P. Novak, D. Stone and J. Burchall, J. Biol. Chetn., in press); however, the translation product from this start site lacked five amino acid residues which were present at the amino terminal end of the sequenced protein. When the GTG was considered as an initiation codon, 24 a better correlation was possible. Of the 38 residues determined by amino acid sequencing, 37 corresponded to those predicted by the DNA sequence. The difference was at residue 37 where the DNA sequence predicted tyrosine rather than glycine. These sequence data indicated that the DHFR structural gene was 471 bases long, had a GTG initiation codon and had a TAA termination codon. Autoradiographs of DNA sequencing gels from which the sequence of the structural gene was obtained are shown in Figure 4 . Identification of the Type I Structural Gene A good correlation was observed not only between the first 38 amino acid residues of the protein sequence and the DNA-deduced amino acids, but also between the observed amino acid composition (D. which was derived from the DNA sequence ( Figure 5 ). Because most of the amino acid residues were found to be in good agreement, the few differences may be attributable to trace contamination by another protein rich in those particular residues. The mass calculated for the deduced gene product was 17,577, a value close to the mass of 18,000 estimated from mobility in denaturing polyacrylamide gels.3
The putative structural gene without its associated promoter or terminator regions was contained within a Hpal fragment which encompassed residues 218 to 707. When this Hpal fragment was inserted in M13mp9, colonies with a phenotype of trimethoprim resistance were isolated at a frequency of 1/10,000 when the culture was plated on a medium containing 50 vig/ml Tp.
In contrast, strains containing the derivative M13mp9 mutated to Tp resistance at a frequency of less than one in 1 x 109.
When the primary DNA sequence proiimai and distal to the proposed structural gene was examined, sequences consistent with features known to be important for the initiation and termination of RNA transcripts Figure 6 ). Conserved residues in the amino terminal portion of the sequence were relatively easy to align. In two areas where few residues were identical, the alignment was rather arbitrary. Residues 76 through 100 of the type I sequence were aligned to take advantage of the avian sequence insertions at positions 80 and 86. A gap was introduced in the type I sequence after position 151 to maximize amino acid homology. When the type I sequence was compared to that of E. coli using the structural alignment, 29% identity was calculated. Inclusion of chemically similar residues increased the level of homology to 44%. Identity with L. casei was 26% and class homology was 40%.
DISCUSSION
The structural gene for a type I Tp-resistant dihydrofolate reductase is carried by transposon 7. This particular enzyme has been difficult to purify and characterize by conventional biochemical means because it is relatively unstable (J. Burchall, personal communication). We undertook the sequence determination of the type I DHFR gene, not only because of its inherent interest, but also because preliminary Tn7 has been specifically implicated in the dissemination of resistance by stably integrating into the chromosomes of pathogenic enterobacteria. 32 * 33 In light of the fact that Tn7 prefers to integrate into the E. coli chromosome rather than plasmid replicons, this development is not surprising. The most interesting finding of this study was that the type I enzyme, the trimethoprim-sensitive bacterial DHFRs of E. coli and L. casei as well as the chicken liver DHFR share significant homology, and further that the homology was greatest in the regions of enzyme structure which are associated with inhibitor and cofactor binding. In the L. case! enzyme NADPH binding involves at least 24 residues. 34 Eight of these residues have been conserved among the DHFR sequences previously determined. Seven of these 8 invariant residues were conserved in the type I sequence. Similarly, some residues involved with methotrexate binding in the L. casei enzyme are invariant among the known enzymes. The type I enzyme contained 4 of the 5 invariant residues. The overall backbone structures of the L. casei, E. coli and chicken liver enzymes are similar.28,34 y e t the amino acid sequences show only about 25% identity. The extent and pattern of primary sequence homology between the type I and either the E. coli or L. casei enzyme approximates the degree of relatedness observed when the E. coli and L. casei enzymes were compared. Thus, it seems likely that the tertiary structure of the type I enzyme is similar to that of the bacterial enzymes.
Although the active site was one region where homology was most notable between the E. coli chromosomal enzyme and the type I DHFR, it is perhaps significant that the aspartate at position 30 ( Figure 6 ), which is involved in methotrexate binding in the sensitive enzyme, is replaced by a glutamate in the methotrexate-resistant type I enzyme. Until this report, all bacterial reductases have been shown to have aspartate at this position, whereas all vertebrate enzymes have glutamate. Perhaps the lower affinity of the type I DHFR and vertebrate reductases for methotrexate is partially associated with the glutamate residue at this key position. In light of the similarity between the type I and E. coli enzymes, it seems reasonable to postulate that these enzymes have evolved from a common ancestral DHFR gene. Basic questions of how dimers of the type I subunit are formed, and particularly, how dimerization affects inhibitor binding, remain unanswered. If the structure of the type I subunit resembles that of the whole chromosomal DHFR, then dimerization may have an important effect on inhibitor binding without significantly altering substrate or cofactor binding.
